Avastin for Colon Cancer: A Conflicted View
In the long-running war to hold down health care spending, controlling cancer…
What Do Patients Really Want? Part I
I recently wrote about an innovator’s dilemma of sorts – or call…
Rebuttal to Last Week’s Blog, Death of Disease Management (Finally)
Last week's blog, The Death of Disease Management, was well....provocative. It received…
FDA Fines Red Cross Again for $9.59 Million–Where Does That Money Go?
I am curious about this as a year ago blood levels were…
Should Popular Doctors Be Paid More?
Starting in October 2012, Medicare will pay 3,000 acute care hospitals more…
Why Healthcare is Finally Going Green
Whether it’s paying a cable bill, mortgage, cell phone bill or other…
End of Life Care: Advice for Physicians Dealing with Families
Writing in Today’s Hospitalist, Dr. Stella Fitzgibbons offers specific and useful advice…
A Theory on Why The FDA Hid Conflicts of Interest
Much has been made of Health and Human Services Secretary Kathleen Sebelius’…
Competition, Investment and Markets in Cell Therapy, Tissue Engineering
Competition in the field of tissue engineering and cell therapy is intense,…
Digital Health Summit: Should it be Advancing or Aligning Innovation?
The Digital Health Summit at the 2012 Consumer Electronics Show commenced this…
